Related Experiment Videos
Aspirin and secondary bleeding after traumatic hyphema
M Marcus1, B Biedner, T Lifshitz
1Department of Ophthalmology, Soroka University Hospital, Beer-Sheba, Israel.
Annals of Ophthalmology
|April 1, 1988
Summary
This study found that aspirin does not significantly increase the risk of rebleeding in patients with traumatic hyphema. Aspirin administration showed no statistically significant difference in rebleeding rates compared to controls.
Area of Science:
- Ophthalmology
- Trauma Care
Background:
- Traumatic hyphema is a common eye injury.
- The potential impact of aspirin on hyphema rebleeding is not fully understood.
Purpose of the Study:
- To investigate the effect of aspirin administration on the risk of rebleeding in patients with traumatic hyphema.
Main Methods:
- A randomized, controlled study involving 51 patients.
- Aspirin (500 mg three times daily) was administered for seven days.
- Rebleeding rates were compared between the aspirin group and the control group.
Main Results:
- Rebleeding occurred in 3 of 23 eyes (13.0%) in the aspirin group.
- Rebleeding occurred in 2 of 28 eyes (7.1%) in the control group.
- The difference in rebleeding rates was not statistically significant (P = .405).
Conclusions:
- Aspirin administration is not a significant factor in the rebleeding of traumatic hyphema.
- Current findings suggest aspirin can be safely used in patients with traumatic hyphema regarding rebleeding risk.